arrow
Back
W

Wojciech Jurczak

maria sklodowska-curie national research institute of oncology

57H-index
648Paper Count
2.1WCitation Count
Published Papers 87
Publication Date
First-line ibrutinib plus venetoclax for non-blastoid mantle cell lymphoma in patients ≥65 years or with TP53 mutations
errBlood
IF23.1
err2026-07-03
err0
errOAAI
errMichael Wang; Marc Hoffmann; Tomasz Wrobel; Marek Trneny; David Belada; Fatih Demirkan; Panayiotis Panayiotidis; Wojciech Jurczak; Pier Luigi Zinzani; Mary-Margaret Keating; Sung-Soo Yoon; Miklós Egyed; Constantine S. Tam; Nathalie A. Johnson; Edith Szafer-Glusman; Jennifer Lin; James P. Dean; Jutta K. Neuenburg; Gottfried von Keudell
errShare
errSave
Brentuximab vedotin and nivolumab in combination with chemotherapy for nonbulky, early-stage classical Hodgkin lymphoma
errBlood
IF23.1
err2026-04-01
err2
PREAI
errAbramson, Jeremy S.; Straus, David J.; Bartlett, Nancy L.; Burke, John M.; Lynch, Ryan C.; Domenech, Eva Domingo; Hess, Brian; Schuster, Steven R.; Linhares, Yuliya; Gandhi, Mitul; Shah, Harsh R.; Jurczak, Wojciech; Re, Alessandro; Hahn, Uwe; Prince, H. Miles; Guo, Wenchuan; Davis, Griffith; Ho, Linda; Fanale, Michelle; Yasenchak, Christopher A.; Lee, Hun Ju
errShare
errSave
Genomic Determinants of Response and Resistance to Pirtobrutinib in Relapsed/Refractory Chronic Lymphocytic Leukemia
errBlood
IF23.1
err2025-10-10
err0
errOAAI
errJennifer R. Brown; Bastien Nguyen; Sai Prasad Desikan; Helen Won; Shady I. Tantawy; Samuel C. McNeely; Narasimha Marella; Hetal S. Randeria; Lauren M. Hanson; Andrew Parker; Salomé Calado Botelho; Jennifer A. Woyach; Krish Patel; Constantine S. Tam; Toby A. Eyre; Chan Y. Cheah; Nirav N. Shah; Paolo Ghia; Wojciech Jurczak; Minna Balbas; Binoj Nair; Paolo Abada; Chunxiao Wang; Denise Wang; Lindsey E. Roeker; Varsha Gandhi; William G. Wierda
errShare
errSave
Large B-cell lymphoma (LBCL): EHA Clinical Practice Guidelines for diagnosis, treatment, and follow-up
err2025-09-23
err0
errOAAI
errCatherine Thieblemont; Maria Gomes Da Silva; Sirpa Leppä; Georg Lenz; Anne-Ségolène Cottereau; Christopher Fox; Armando Lopez-Guillermo; Timothy Illidge; Wojciech Jurczak; Hans Eich; Igor Aurer; Marek Trneny; Andy Andreas Rosenwald; Andrew Davies; Ben (Gerben) Zwezerijnen; Natacha Bolanos; Maja Marković; Jean-Philippe Jais; Florence Broussais; Martin Dreyling; Umberto Vitolo; Hervé Tilly; Marie-José Kersten
errShare
errSave
Bridging gaps in clinical trial accessibility and reimbursement for large B-cell lymphoma therapies across Europe
err2025-09-23
err0
errOAAI
errFlorence Broussais; Elise Pennings; Natacha Bolanos; Lorna Warwick; Robin Doeswijk; Gauthier Quinonez; Andrii Lebeda; Maria Gomes Da Silva; Sirpa Leppä; Georg Lenz; Anne-Ségolène Cottereau; Christopher Fox; Armando Lopez-Guillermo; Timothy Illidge; Wojciech Jurczak; Hans Eich; Igor Aurer; Marek Trneny; Andy Andreas Rosenwald; Andrew Davies; Ben (Gerben) Zwezerijnen; Jean-Philippe Jais; Martin Dreyling; Umberto Vitolo; Hervé Tilly; Catherine Thieblemont; Marie Jose Kersten
errShare
errSave
Outcomes following transition from ibrutinib to zanubrutinib in patients with Waldenström macroglobulinemia from ASPEN
err2025-09-11
err0
errOAAI
errRamón García-Sanz; Roger G. Owen; Wojciech Jurczak; Meletios A. Dimopoulos; Helen McCarthy; Gavin Cull; Stephen S. Opat; Jorge J. Castillo; Marie José Kersten; Björn E. Wahlin; Sebastian Grosicki; Radha Prathikanti; Tian Tian; Heather Allewelt; Aileen Cleary Cohen; Constantine S. Tam
errShare
errSave
Acalabrutinib-obinutuzumab improves survival vs chemoimmunotherapy in treatment-naive CLL in the 6-year follow-up of ELEVATE-TN
errBlood
IF23.1
err2025-04-11
err0
errOAAI
errJeff P. Sharman; Miklos Egyed; Wojciech Jurczak; Alan Skarbnik; Krish Patel; Ian W. Flinn; Manali Kamdar; Talha Munir; Renata Walewska; Marie Hughes; Laura Maria Fogliatto; Yair Herishanu; Versha Banerji; George Follows; Patricia Walker; Paolo Ghia; Ann Janssens; John C. Byrd; Emmanuelle Ferrant; Alessandra Ferrajoli; William G. Wierda; Catherine Wangui Wachira; Batul T. Suterwala; Paulo Miranda; Veerendra Munugalavadla; Chuan-Chuan Wun; Jennifer A. Woyach
errShare
errSave
A First-in-Human Phase I Study of LOXO-338, an Oral Selective Bcl-2 Inhibitor, in Patients With Advanced Hematologic Malignancies
err2025-01-28
err0
PREAI
errMichal Kwiatek; Guru Subramanian Guru Murthy; Marc Hoffmann; Benoit Tessoulin; Alexey Danilov; Alvaro J. Alencar; Nirav N. Shah; Hervé Ghesquieres; Steven Le Gouill; Wojciech Jurczak; Hongmei Han; Eunice Yuen; Vishalkumar Patel; Yingying Guo-Avrutin; James M. Pauff; Lindsey E. Roeker
errShare
errSave
Efficacy and safety in a 4-year follow-up of the ELEVATE-TN study comparing acalabrutinib with or without obinutuzumab versus obinutuzumab plus chlorambucil in treatment-naive chronic lymphocytic leukemia (Dec, 10.1038/s41375-024-02487-1, 2024)
errLEUKEMIA
IF13.4
err2024-12-03
err0
errOAAI
errSharman, Jeff P.; Egyed, Miklos; Jurczak, Wojciech; Skarbnik, Alan; Pagel, John M.; Flinn, Ian W.; Kamdar, Manali; Munir, Talha; Walewska, Renata; Corbett, Gillian; Fogliatto, Laura Maria; Herishanu, Yair; Banerji, Versha; Coutre, Steven; Follows, George; Walker, Patricia; Karlsson, Karin; Ghia, Paolo; Janssens, Ann; Cymbalista, Florence; Woyach, Jennifer A.; Ferrant, Emmanuelle; Wierda, William G.; Munugalavadla, Veerendra; Yu, Ting; Wang, Min Hui; Byrd, John C.
errShare
errSave
Acalabrutinib in Patients with Mantle Cell Lymphoma and Chronic Lymphocytic Leukemia Subjected to Allogeneic Hematopoietic Stem Cell Transplantation. a Phase 2 Study By the Polish Lymphoma Research Group
errBLOOD
IF23.1
err2024-11-05
err0
PREAI
errGiebel, Sebastian; Czyz, Anna; Hus, Iwona; Gil, Lidia; Giannopoulos, Krzysztof; Romejko-Jarosinska, Joanna; Majcherek, Maciej; Szeremet, Agnieszka; Wache, Anna; Kwasnik, Paulina; Mendrek, Wlodzimierz; Jurczak, Wojciech
errShare
errSave
Golseek-1: A Phase 3, Double-Blind, Randomized Study Comparing the Efficacy and Safety of Golcadomide Plus R-CHOP Vs R-CHOP in Patients with Previously Untreated, High-Risk, Large B-Cell Lymphoma
errBLOOD
IF23.1
err2024-11-05
err0
PREAI
errHoffmann, Marc; Vassilakopoulos, Theodoros; Munoz, Javier; Westin, Jason R.; Bouzani, Maria; Jurczak, Wojciech; Kwiatek, Michal; Berkovits, Alejandro; Huang, Tai-Chung; Sudhindra, Akshay; Patel, Arpankumar; Boucaud, Floriane; Petel, Adrien; Nowakowski, Grzegorz S.
errShare
errSave
Pirtobrutinib monotherapy in Bruton tyrosine kinase inhibitor-intolerant patients with B-cell malignancies: results of the phase I/II BRUIN trial
err2024-10-03
err2
errOAAI
errShah, Nirav N.; Wang, Michael; Roeker, Lindsey E.; Patel, Krish; Woyach, Jennifer A.; Wierda, William G.; Ujjani, Chaitra S.; Eyre, Toby A.; Zinzani, Pier Luigi; Alencar, Alvaro J.; Ghia, Paolo; Lamanna, Nicole; Hoffmann, Marc S.; Patel, Manish R.; Flinn, Ian; Gerson, James N.; Ma, Shuo; Coombs, Catherine C.; Cheah, Chan Y.; Lech-Maranda, Ewa; Fakhri, Bita; Kim, Won Seog; Barve, Minal A.; Cohen, Jonathon B.; Jurczak, Wojciech; Munir, Talha; Thompson, Meghan C.; Tsai, Donald E.; Bao, Katherine; Cangemi, Nicholas A.; Kherani, Jennifer F.; Walgren, Richard A.; Han, Hongmei; Ruppert, Amy S.; Brown, Jennifer R.
errShare
errSave
Epcoritamab in relapsed/refractory large B-cell lymphoma: 2-year follow-up from the pivotal EPCORE NHL-1 trial
errLEUKEMIA
IF13.4
err2024-09-25
err0
errOAAI
errThieblemont, Catherine; Karimi, Yasmin H.; Ghesquieres, Herve; Cheah, Chan Y.; Clausen, Michael Roost; Cunningham, David; Jurczak, Wojciech; Do, Young Rok; Gasiorowski, Robin; Lewis, David John; Kim, Tae Min; van der Poel, Marjolein; Poon, Michelle Limei; Feldman, Tatyana; Linton, Kim M.; Sureda, Anna; Hutchings, Martin; Dinh, Minh H.; Kilavuz, Nurgul; Soong, David; Mark, Thomas; Sacchi, Mariana; Phillips, Tycel; Lugtenburg, Pieternella J.
errShare
errSave
Safety and efficacy of acalabrutinib plus bendamustine and rituximab in patients with treatment-naïve or relapsed/refractory mantle cell lymphoma: phase Ib trial
err2024-09-05
err1
errOAAI
errPhillips, Tycel; Wang, Michael; Robak, Tadeusz; Gallinson, David; Stevens, Don; Patel, Krish; Ramadan, Safaa; Wun, Chuan-Chuan; Jurczak, Wojciech; Smith, Stephen D.
errShare
errSave
Pirtobrutinib, a highly selective, non-covalent (reversible) BTK inhibitor in patients with B-cell malignancies: analysis of the Richter transformation subgroup from the multicentre, open-label, phase 1/2 BRUIN study
err2024-09-01
err2
PREAI
errWierda, William G.; Shah, Nirav N.; Cheah, Chan Y.; Lewis, David; Hoffmann, Marc S.; Coombs, Catherine C.; Lamanna, Nicole; Ma, Shuo; Jagadeesh, Deepa; Munir, Talha; Wang, Yucai; Eyre, Toby A.; Rhodes, Joanna M.; McKinney, Matthew; Lech-Maranda, Ewa; Tam, Constantine S.; Jurczak, Wojciech; Izutsu, Koji; Alencar, Alvaro J.; Patel, Manish R.; Seymour, John F.; Woyach, Jennifer A.; Thompson, Philip A.; Abada, Paolo B.; Ho, Caleb; McNeely, Samuel C.; Marella, Narasimha; Nguyen, Bastien; Wang, Chunxiao; Ruppert, Amy S.; Nair, Binoj; Liu, Hui; Tsai, Donald E.; Roeker, Lindsey E.; Ghia, Paolo
errShare
errSave
The PI3Kδ inhibitor zandelisib on intermittent dosing in relapsed/refractory follicular lymphoma: Results from a global phase 2 study
err2024-08-06
err0
errOAAI
errZelenetz, Andrew D.; Jurczak, Wojciech; Ribrag, Vincent; Linton, Kim; Collins, Graham P.; Jimenez, Javier L.; Bishton, Mark; Dholaria, Bhagirathbhai; Mengarelli, Andrea; Phillips, Tycel J.; Sungala, Nagendraprasad; Musuraca, Gerardo; Sheehy, Oonagh; Van Den Neste, Eric; Odera, Mitsuhiko; Miao, Lu; Gold, Daniel P.; Ghalie, Richard G.; Zinzani, Pier L.
errShare
errSave
Epcoritamab monotherapy in patients with relapsed or refractory follicular lymphoma (EPCORE NHL-1): a phase 2 cohort of a single-arm, multicentre study
err2024-08-01
err8
PREAI
errLinton, Kim M.; Vitolo, Umberto; Jurczak, Wojciech; Lugtenburg, Pieternella J.; Gyan, Emmanuel; Sureda, Anna; Christensen, Jacob Haaber; Hess, Brian; Tilly, Herve; Cordoba, Raul; Lewis, David John; Okada, Craig; Hutchings, Martin; Clausen, Michael Roost; Sancho, Juan-Manuel; Cochrane, Tara; Leppa, Sirpa; Chamuleau, Martine E. D.; Gernhardt, Diana; Altintas, Isil; Liu, Yan; Ahmadi, Tahamtan; Dinh, Minh H.; Hoehn, Daniela; Favaro, Elena; Elliott, Brian; Thieblemont, Catherine; Vose, Julie M.
errShare
errSave
Biomarker analysis of the ASPEN study comparing zanubrutinib with ibrutinib for patients with Waldenström macroglobulinemia
err2024-03-28
err3
errOAAI
errTam, Constantine S.; Opat, Stephen; D'Sa, Shirley; Jurczak, Wojciech; Lee, Hui-Peng; Cull, Gavin; Owen, Roger G.; Marlton, Paula; Wahlin, Bjoern E.; Garcia-Sanz, Ramon; McCarthy, Helen; Mulligan, Stephen; Tedeschi, Alessandra; Castillo, Jorge J.; Czyz, Jaros law; De Larrea, Carlos Fernandez; Belada, David; Libby, Edward; Matous, Jeffrey; Motta, Marina; Siddiqi, Tanya; Tani, Monica; Trneny, Marek; Minnema, Monique C.; Buske, Christian; Leblond, Veronique; Treon, Steven P.; Trotman, Judith; Wu, Binghao; Yu, Yiling; Shen, Zhirong; Chan, Wai Y.; Schneider, Jingjing; Allewelt, Heather; Cohen, Aileen; Dimopoulos, Meletios A.
errShare
errSave
Peripheral pharmacodynamic activity of epcoritamab as monotherapy and in combination with rituximab plus lenalidomide in patients with follicular lymphoma
err2024-03-22
err0
PREAI
errSi, Han; Zhang, Jimin; Wielgos-Bonvallet, Monica; Falchi, Lorenzo; Linton, Kim; Jurczak, Wojciech; Belada, David; Altintas, Isil; Sacchi, Mariana; Favaro, Elena; Rana, Ali; Hoehn, Daniela; Soong, David; Chiu, Christopher W.; Jure-Kunkel, Maria
errShare
errSave
errShare
errSave